Vynleads (VYND) Net Income towards Common Stockholders (2020 - 2026)
Vynleads' (VYND) quarterly Net Income towards Common Stockholders came in at -$96956.0 in Q1 2026, down 19.74% year-on-year from -$120807.1 in Q1 2025, and down 64.48% on a QoQ basis from -$58946.0 in Q4 2025.
Vynleads (VYND) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
Vynleads (VYND) has 7 years of Net Income towards Common Stockholders data on file, last reported at -$96956.0 in Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 19.74% year-over-year to -$96956.0 in Q1 2026; TTM through Mar 2026 was -$271052.0, a 3.63% decrease from a year earlier, with the FY2025 full-year figure at -$255066.0, up 2.35% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$96956.0, down from -$58946.0 in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for VYND reached as high as -$57081.0 in Q2 2025 and fell as low as -$96956.0 in Q1 2026.
- Historically, Net Income towards Common Stockholders has averaged -$67515.9 across 5 years, with a median of -$62424.0 in 2023.
- Across the five-year window, Net Income towards Common Stockholders gained 17.33% in 2022 and slipped 19.74% in 2026, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at -$70858.0 in 2022, then grew by 14.78% to -$60383.0 in 2023, then dropped by 5.41% to -$63647.0 in 2024, then rose by 7.39% to -$58946.0 in 2025, then slumped by 64.48% to -$96956.0 in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$96956.0 in Q1 2026, -$58946.0 in Q4 2025, and -$58069.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.17 Bn | 24.86 Bn | 662.02 Mn | 260.94 Mn |
| 2 | BrightSpring Health Services | 14.66 Bn | 13.76 Bn | 482.22 Mn | 148.77 Mn |
| 3 | Healthequity | 8.40 Bn | 8.13 Bn | 256.31 Mn | 69.42 Mn |
| 4 | Hinge Health | 5.97 Bn | 5.65 Bn | 154.23 Mn | 34.01 Mn |
| 5 | 10x Genomics | 5.88 Bn | 5.34 Bn | 106.18 Mn | -13.47 Mn |
| 6 | MiniMed | 4.51 Bn | 4.21 Bn | 480.00 Mn | -185.00 Mn |
| 7 | Waystar Holding | 4.46 Bn | 4.40 Bn | 216.84 Mn | 43.28 Mn |
| 8 | Doximity | 3.95 Bn | 3.21 Bn | 125.97 Mn | 19.11 Mn |
| 9 | Privia Health | 3.13 Bn | 2.71 Bn | - | 3.71 Mn |
| 10 | Vynleads | 7.51 Mn | 7.51 Mn | -2,028.00 | -96,956.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96,956.00 |
| Dec 31, 2025 | -58,946.00 |
| Sep 30, 2025 | -58,069.00 |
| Jun 30, 2025 | -57,081.00 |
| Mar 31, 2025 | -80,970.00 |
| Dec 31, 2024 | -63,647.00 |
| Sep 30, 2024 | -58,658.00 |
| Jun 30, 2024 | -58,271.00 |
| Mar 31, 2024 | -80,616.00 |
| Dec 31, 2023 | -60,383.00 |
| Sep 30, 2023 | -62,424.00 |
| Jun 30, 2023 | -66,063.00 |
| Mar 31, 2023 | -74,567.00 |
| Dec 31, 2022 | -70,858.00 |
| Sep 30, 2022 | -59,956.00 |
| Jun 30, 2022 | -58,118.00 |
| Mar 31, 2022 | -82,187.00 |
| Dec 31, 2021 | -75,728.00 |
| Sep 30, 2021 | -50,091.00 |
| Jun 30, 2021 | -70,304.00 |